Form4insider filings, from the source

SEC Form 4 · accession 0000905148-16-001704

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
R Kent McGaughy Jr.
Director · 10% Owner
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 2:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A common stockF1,F7,F8Jun 24, 2016P8,909$18.3501A403,686ISee footnote
Class A common stockF2,F7,F8Jun 24, 2016P42,526$19.4905A446,212ISee footnote
Class A common stockF3,F7,F8Jun 27, 2016P21,968$19.1749A468,180ISee footnote
Class A common stockF4,F8holding———4,591IBy Lagos Trust
Class A common stockF5,F8holding———280IBy Traweek Children's Trust
Class A common stockF6,F8holding———2,739ISee footnote
Class A common stockholding———25,004D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses